After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.

Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.

A long-standing collaboration between PNNL and Oregon State University to study harmful chemicals at federally designated hazardous waste sites primarily across the Pacific Northwest has been awarded a five-year, $12.7 million grant.

A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.

The recent coronavirus pandemic shows just how quickly a deadly pathogen can sweep across the globe, killing tens of thousands in the U.S. and disrupting daily life for millions more in the span of a few months.

PNNL research scientists Jay Grate and Matthew O'Hara co-authored a chapter in the fourth edition of the Handbook of Radioactivity Analysis. 

Artificial intelligence helps researchers identify metabolites, the small molecules that underlie life.

A PNNL scientist is studying the structures of the proteins on the surface of the novel coronavirus, using NMR spectroscopy to reveal information about the molecular toolkit that holds the keys to a vaccine or treatment.

Researchers adding water to the surface of alumina measured some surprising results that raise important questions regarding the fundamental reactions that govern chemical transformations of aluminum oxides and hydroxides.

Scientists at the Interfacial Dynamics in Radioactive Environments and Materials (IDREAM) sort out which compounds are present and their concentrations, providing an important new tool with broad applicability.

Combining its strength in biological sciences and data analytics, researchers at the Department of Energy's PNNL are working to enable a quick response to a biological incident — whether intentional, accidental or natural.

A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.

The world’s largest scientific society honored Sue B. Clark, a PNNL and WSU chemist, for contributions toward resolving our legacy of radioactive waste, advancing nuclear safeguards, and developing landmark nuclear research capabilities.

The researchers treated human pancreatic islets with substances produced by the body and thought to be involved in the diabetes disease process.

While it’s one small step forward for mouse research, it’s a big step forward for understanding proteins, the molecular workhorses in biological organisms.

PNNL’s Nuclear Process Science Initiative (NPSI) has developed a book that examines processes used to separate nuclear materials.

A new drug delivery method designed by researchers at PNNL and Washington State University (WSU) has shown it can target and kill lung cancer cells.

The ANS award will be presented at the Global Top Fuel 2019 Conference this September in Seattle, and comes amid several recent recognitions for Paviet.

The first phase, which started in 2014, generated foundational data from developing mouse and human lungs, created a web portal for public data sharing, and established a repository of human lung tissues.